Inflammatory bowel diseases (IBD) such as Crohns disease and ulcerative colitis can lead to complications including bleeding
Semaglutide is a once-weekly injection that supports weight loss and helps regulate blood sugar
Ozempic, which contains the active ingredient semaglutide, is licensed for the treatment of diabetes in the UK (although was previously prescribed off-label for weight loss), while Wegovy is used for weight management
For oral semaglutide, the average maintenance dose splits by product
Xue M, Kim CS, Healy AR, Wernke KM, Wang Z, Frischling MC, et al
Significant weight reduction generally becomes apparent after a few months of consistent use alongside dietary improvements